The Patient Transition Guide is intended to support UK-based adult patients who have already been prescribed Rybelsus during the transition from the previous formulation to the new formulation. This document outlines the differences and similarities between the previous and new dosages, provides detailed information on the dosages, and explains how the medication should be administered.